http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01261364-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_324beb8b942a3a6ed1f1f576bcd76c45
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
filingDate 1988-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_691d17003b2213d06f7bf7a1d19caf4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f97f6e94535872a7684b81811b5e5aee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a04575e5e91bf33d9c70ec79f22ad57e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8a2ec84de2e9d82cd3475dcd3e92e81
publicationDate 1989-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H01261364-A
titleOfInvention Novel azetidinone derivative and muscle relaxant containing said derivative
abstract NEW MATERIAL:An azetidinone derivative expressed by formula I (R 1 is straight or branched chain alkyl or aryl which may have a substituent group; R 2 is aryl which may have a substituent group; R 3 and R 4 are 1W6C alkyl or 4-W8-membered heterocyclic ring as NR 3 R 4 which may contain other hetero- atoms; n is 2, 3 or 4). n EXAMPLE: cis-3-Benzamido-4-phenyl-1-(3-piperidinopropyl)-2-azetidinone. n USE: A muscle relaxant. n PREPARATION: A compound expressed by formula (a) (X is halogen) is reacted with a Schiff base expressed by formula (b) (Y is halogen or NR 3 R 4 ) in the presence of a base, such as triethylamim, in a solvent without participating in the reaction to afford a compound expressed by formula (c). The imide group in the resultant compound is then converted into amino group in an alcohol using hydrazide hydrate to provide a compound expressed by formula (d), which is further acylated and reacted with an amine expressed by the formula NHR 3 R 4 (Y is halogen) to afford the compound expressed by formula I. n COPYRIGHT: (C)1989,JPO&Japio
priorityDate 1988-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540210
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70385562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14651838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235801696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14651839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235801708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235801714

Total number of triples: 32.